|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 2167128 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08784834.7 |
| Date of filing the European patent application | 2008-07-17 | |
| (97) | Date of publication of the European application | 2010-03-31 |
| (45) | Date of publication and mention of the grant of the patent | 2012-10-24 |
| (46) | Date of publication of the claims translation | 2012-12-27 |
| (86) | Number | PCT/EP2008/005852 |
| Date | 2008-07-17 |
| (87) | Number | WO 2009/010290 |
| Date | 2009-01-22 |
| (30) | Number | Date | Country code |
| 07013964 | 2007-07-17 | EP |
| (72) |
GOODMAN, Simon, DE
HAHN, Diane, DE
MITJANS, Francesc, ES
ADAN, Jaume, ES
LO, Kin-Ming, US
|
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Genetiškai modifikuoti anti-alfa-v integrino hibridiniai antikūnai |
| ENGINEERED ANTI-ALPHA V- INTEGRIN HYBRID ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2015-07-08 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2016-07-17 |